Edward-Elmhurst Health
VC Fund
Naperville, United States
Edward-Elmhurst Health is an integrated health system comprised of three hospitals.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Edward-Elmhurst Health invests in
Health CareMedical DeviceBiotechnologyMedicalHospital
Stages Edward-Elmhurst Health invests in
SeedFunding RoundPre-SeedSeries BVenture - Series Unknown
Countries Edward-Elmhurst Health invests in
United States
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Bill Kottmann
|
|||
John Lee
|
|||
Investment Focus
Industry
- Health Care 7 (70%)
- Medical Device 4 (40%)
- Biotechnology 2 (20%)
- Medical 1 (10%)
- Hospital 1 (10%)
Stage
- Seed 4 (40%)
- Funding Round 3 (30%)
- Pre-Seed 1 (10%)
- Series B 1 (10%)
- Venture - Series Unknown 1 (10%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Bill Kottmann
CEO
|
CEO | Total investments: 0 | Find email | |
|
John Lee
CMIO
|
CMIO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Memora Health
|
Memora Health, the leading intelligent care enablement platform, helps clinicians focus on top-of-license practice while proactively engaging patients along complex care journeys. Memora partners with leading health systems, health plans, and digital health companies to transform the care delivery process for care teams and patients. Our platformdigitizes and automates high-touch clinical workflows, supercharging care teams by intelligently triaging patient-reported concerns and data to appropriate care team members and providing patients with proactive, two-way communication and support. Memora Health is headquartered in San Francisco, CA, with clients and team members around the country, and is backed by Andreessen Horowitz, Transformation Capital, General Catalyst, AlleyCorp, Frist Cressey Ventures, Martin Ventures, Kevin Durant and Rich Kleiman's Thirty Five Ventures, and several other strategic healthcare groups.To learn more about Memora’s vision to make care more actionable, accessible and always-on, visit memorahealth.com. | $30M / Apr 18, 2023 | |
Digital Diagnostics
|
Digital Diagnostics, formerly IDx, is a pioneering AI diagnostics company founded with a mission to transform the quality, accessibility, equity, and affordability of healthcare worldwide through the application of technology in the medical diagnosis and treatment process. Founded by Michael Abramoff, MD, PhD, a fellowship-trained retinaspecialist, neuroscientist, and computer engineer, Digital Diagnostics developed a patented biomarker-based approach to build an autonomous AI platform that makes clinical decisions without human intervention, removing the diagnostic burden of common diseases from specialists. Digital Diagnostics is paving the way for autonomous AI diagnosis to become the new standard of care, helping to democratize healthcare and close care gaps to improve patient outcomes. By working closely with patient advocacy groups, federal regulators, and other quality of care and ethics-focused stakeholders, Digital Diagnostics is working with the healthcare system to enable the continued adoption of autonomous AI. | $75M / Series B / Aug 23, 2022 | |
NovaXS Biotech
|
NovaXS is developing the next generation of smart needle-free drug delivery platform that improves the medication adherence and optimizes the treatment outcomes. | $1.5M / Seed / Mar 15, 2022 | |
NXgenPort
|
NXgenPort Inc is addressing an unmet need in cancer care by remotely monitoring patients between chemotherapy visits with an implanted Smart Port. By measuring cell counts and heart function in vivo, NGP will alert physicians to signs of infection, reduce hospitalizations, and gather important physiological data to improve patient outcomes. Thereis additional value for cancer researchers and drug delivery stakeholders to remotely monitor a participant's biological response to interventions. | Pre-Seed / Mar 01, 2022 | |
|
Memora Health
|
Memora Health, the leading intelligent care enablement platform, helps clinicians focus on top-of-license practice while proactively engaging patients along complex care journeys. Memora partners with leading health systems, health plans, and digital health companies to transform the care delivery process for care teams and patients. Our platformdigitizes and automates high-touch clinical workflows, supercharging care teams by intelligently triaging patient-reported concerns and data to appropriate care team members and providing patients with proactive, two-way communication and support. Memora Health is headquartered in San Francisco, CA, with clients and team members around the country, and is backed by Andreessen Horowitz, Transformation Capital, General Catalyst, AlleyCorp, Frist Cressey Ventures, Martin Ventures, Kevin Durant and Rich Kleiman's Thirty Five Ventures, and several other strategic healthcare groups.To learn more about Memora’s vision to make care more actionable, accessible and always-on, visit memorahealth.com. | $40M / Venture - Series Unknown / Feb 15, 2022 | |
Walela
|
Walela is a medical device company that develops sensor technology to improve fetal and maternal outcomes. It measures fetal heart rate and blood pH using its specialized medical technology. The company was founded by James Balman in 2021 and is headquartered in Chicago, Illinois. | $237.5K / Seed / Nov 21, 2021 | |
Ready, Set, Food!
|
Ready, Set, Food! makes it easy for parents reduce their baby's risk of developing peanut, egg, and milk allergies by up to 80% with our gentle, daily system. | $3.5M / Jun 03, 2021 | |
|
Ready, Set, Food!
|
Ready, Set, Food! makes it easy for parents reduce their baby's risk of developing peanut, egg, and milk allergies by up to 80% with our gentle, daily system. | $3.5M / Seed / Jun 03, 2021 | |
|
Memora Health
|
Memora Health, the leading intelligent care enablement platform, helps clinicians focus on top-of-license practice while proactively engaging patients along complex care journeys. Memora partners with leading health systems, health plans, and digital health companies to transform the care delivery process for care teams and patients. Our platformdigitizes and automates high-touch clinical workflows, supercharging care teams by intelligently triaging patient-reported concerns and data to appropriate care team members and providing patients with proactive, two-way communication and support. Memora Health is headquartered in San Francisco, CA, with clients and team members around the country, and is backed by Andreessen Horowitz, Transformation Capital, General Catalyst, AlleyCorp, Frist Cressey Ventures, Martin Ventures, Kevin Durant and Rich Kleiman's Thirty Five Ventures, and several other strategic healthcare groups.To learn more about Memora’s vision to make care more actionable, accessible and always-on, visit memorahealth.com. | $10.5M / Seed / May 11, 2021 | |
Smart Choice MRI
|
Smart Choice MRI, LLC provides high-quality magnetic resonance imaging services for a fair, transparent price of $600 or less. All scans are preformed using advanced GE technology and are read by board certified, sub-specialized radiologists at the Cleveland Clinic. Founded in 2006, it currently has locations across Illinois and Wisconsin. | $7M / May 16, 2016 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
Health Care Investors
43,014 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Medical Investors
18,848 investors
Medical Device Investors
11,047 investors
Health Care VC Funds
32,370 investors
Biotech VC Funds
18,864 investors
Biotechnology VC Funds
17,016 investors
Medical VC Funds
16,214 investors
FAQ
What does Edward-Elmhurst Health invest in?
Edward-Elmhurst Health invests primarily in Health Care, Medical Device and Biotechnology startups, most often at Seed and Funding Round stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Edward-Elmhurst Health?
Public channels for Edward-Elmhurst Health include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Edward-Elmhurst Health?
The team at Edward-Elmhurst Health includes Bill Kottmann (CEO) and John Lee (CMIO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
